Approvals/CIMA-AEMPS/VENLAFAXINA RETARD TEVA-RATIOPHARM 150 MG CAPSULAS DURAS DE LIBERACION PROLONGADA

Approved

STANDARD

VENLAFAXINA RETARD TEVA-RATIOPHARM 150 MG CAPSULAS DURAS DE LIBERACION PROLONGADA

Teva B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 69313d70bea406ff
Drug Cima Aemps Name: VENLAFAXINA RETARD TEVA-RATIOPHARM 150 MG CAPSULAS DURAS DE LIBERACION PROLONGADA
Register Number: 87921
Holder Company Name: Teva B.V.
Marketing Company Name: Teva Pharma S.L.U.
Holder Company Detail Path: /organization/teva-pharma-b-v
Authorization Date: 2022-07-01
Dosage Form: CÁPSULA DURA DE LIBERACIÓN PROLONGADA
Dose: 150 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Teva B.V.
Company Detail Path: /organization/teva-pharma-b-v

VENLAFAXINA HIDROCLORURO

170,5 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 1, 2022

Approval ID

69313d70bea406ff

Type

Standard